Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SCLXW
SCLXW
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SCLXW News
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
1d ago
moomoo
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
1d ago
moomoo
SCILEX HOLDING COMPANY INVESTS $20 MILLION IN QUANTUM SCAN HOLDINGS, INC. TO TAP INTO TRILLION-DOLLAR PREVENTIVE DIAGNOSIS AND PROGNOSIS SECTORS
Jan 30 2026
moomoo
Scilex Holding Company Secures Global Exclusive License for Tokenizing and Monetizing Real-World Assets in Genomics, DNA Data, Diagnostics, Therapeutics, and Genetic Drug Information from Datavault AI
Nov 04 2025
Newsfilter
Scilex Holding Company Unveils $150 Million Strategic Investment in Bitcoin for Datavault AI
Sep 25 2025
Newsfilter
Scilex Holding Company Forms Partnership with Biconomy.com to Develop Future Cryptocurrency Strategies and Manage Treasury Operations
Sep 24 2025
Newsfilter
Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. Confirm Completion of Their Announced Business Merger
Sep 22 2025
Newsfilter
Scilex Holding Company (Nasdaq: SCLX) Announces $20 Million Private Placement Agreement for Semnur Pharmaceuticals, with CEO Jaisim Shah Committing Full Time to Accelerate SP-102's Regulatory Approval and Commercialization for Lumbosacral Radicular Pain/Sciatica Treatment
Aug 21 2025
Newsfilter
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
Aug 13 2025
Newsfilter
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
Jun 05 2025
Newsfilter
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
Apr 30 2025
Newsfilter
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
undefined NaN NaN
Newsfilter
Show More News
